{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:04:54Z","timestamp":1791140694711,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Uterine carcinosarcoma (UCS), or malignant mixed M\u00fcllerian tumor, is a cancer that include both carcinomatous and sarcomatous components, resembling endometrial carcinoma. A 55-year-old woman was admitted to the hospital with postmenopausal vaginal bleeding. Gross examination of the specimen revealed brittle tissue in the fundus and the left wall of the endometrium. Postoperative pathology revealed a mixture of well-differentiated endometrioid adenocarcinoma and osteosarcoma. The patient was never given birth, which may be relevant to the diagnosis. Literature review suggests that being nulliparous may be a significant risk factor for developing uterine carcinosarcoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>In December 2023, a 55-year-old female patient was admitted to the hospital with postmenopausal vaginal bleeding. Hysteroscopic surgery was performed, and the postoperative pathology showed endometrial cancer accompanied by ossified tissue with necrosis. The immunohistochemical results indicated positive Estrogen receptors (ER), positive Progesterone receptors (PR), ki67 positivity at 70%, negative PTEN, mutated positive p53, focal positive Pax-8, positive SATB2, positive Cytokeratin 7 (CK7), positive EMA and positive Vimentin (Vim). The patient was diagnosed with Uterine carcinosarcoma. On December 18, 2023, the patient underwent partial vaginal resection, bilateral salpingo-oophorectomy, pelvic lymph node dissection, and a sub-extensive laparoscopic hysterectomy. Postoperatively, the patients received radiotherapy and four cycles of chemotherapy in the DC regimen. As of July 2024, laboratory and impact test results showed no tumor recurrence. The patient\u2019s disease-free survival (DFS) was seven months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The rate of childless in patients with uterine carcinosarcoma is at a high level.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1472416","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:12:04Z","timestamp":1733893924000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Carcinosarcoma of uterus in nulliparous women"],"prefix":"10.3389","volume":"14","author":[{"given":"Feiyue","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-004073","article-title":"Endometrial carcinosarcoma","volume":"33","author":"Bogani","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.critrevonc.2014.10.013","article-title":"Rare uterine cancer: carcinosarcomas. Review from histology to treatment","volume":"94","author":"Artioli","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-022-01014-7","article-title":"Beyond serous: treatment options for rare endometrial cancers","volume":"23","author":"Crane","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103369","article-title":"Uterine carcinosarcoma: An overview","volume":"163","author":"Pezzicoli","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2022.07.031","article-title":"Uterine sarcomas and rare uterine mesenchymal tumors with Malignant potential. Diagnostic guidelines of the French Sarcoma Group and the Rare Gynecological Tumors Group","volume":"167","author":"Croce","year":"2022","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3182979b27","article-title":"Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy","volume":"38","author":"Pacaut","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18051100","article-title":"Target therapies for uterine carcinosarcomas: current evidence and future perspectives","volume":"18","author":"Vitale","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-022-01563-1","article-title":"Clinico-pathological characteristics, management, and prognostic factors of patients with uterine carcinosarcoma: a retrospective analysis","volume":"14","author":"Goyal","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.suronc.2019.02.002","article-title":"Tumor characteristics and outcome of uterine carcinosarcoma in women aged \u226580 years","volume":"29","author":"Matsuo","year":"2019","journal-title":"Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000452277","article-title":"Malignant mixed m\u00fcllerian tumour of the uterus: analysis of 44 cases","volume":"92","author":"Grasso","year":"2017","journal-title":"Oncology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.20344\/amp.7078","article-title":"Uterine carcinosarcoma: clinicopathological features and prognostic factors","volume":"29","author":"Luz","year":"2016","journal-title":"Acta Med Port"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-015-0859-7","article-title":"Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group","volume":"21","author":"Harano","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/igc.0000000000000720","article-title":"Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database","volume":"26","author":"Hosh","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-2843-7","article-title":"Uterine sarcoma-current management and experience from a regional cancer centre in North India","volume":"288","author":"Biswas","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1514010","article-title":"Endometrial cancer","volume":"383","author":"Lu","year":"2020","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14033","article-title":"Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival","volume":"158","author":"Raffone","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ijgo.13937","article-title":"Prognostic value of the TCGA molecular classification in uterine carcinosarcoma","volume":"158","author":"Travaglino","year":"2022","journal-title":"Int J Gynaecol Obstet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2021.05.003","article-title":"Uterine carcinosarcomas: From pathology to practice","volume":"162","author":"Toboni","year":"2021","journal-title":"Gynecol Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5010210","article-title":"Management of endometrial cancer: molecular identikit and tailored therapeutic approach","volume":"50","author":"D\u2019Oria","year":"2023","journal-title":"CEOG"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5011229","article-title":"Pathogenesis and treatments of endometrial carcinoma","volume":"50","author":"Besharat","year":"2023","journal-title":"CEOG"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/470795","article-title":"Uterine carcinosarcomas (malignant mixed m\u00fcllerian tumours): a review with special emphasis on the controversies in management","volume":"2011","author":"Kanthan","year":"2011","journal-title":"Obstet Gynecol Int"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.01.042","article-title":"Social determinants of health in uterine carcinosarcoma","volume":"184","author":"Aroche Gutierrez","year":"2024","journal-title":"Gynecol Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/09622802231172043","article-title":"Detecting the skewness of data from the five-number summary and its application in meta-analysis","volume":"32","author":"Shi","year":"2023","journal-title":"Stat Methods Med Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem046","article-title":"International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care","volume":"22","author":"Boivin","year":"2007","journal-title":"Hum Reprod"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)32708-2","article-title":"A Lancet Commission on 70 years of women\u2019s reproductive, maternal, newborn, child, and adolescent health in China","volume":"397","author":"Qiao","year":"2021","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoad007","article-title":"Financial costs of assisted reproductive technology for patients in low- and middle-income countries: a systematic review","volume":"2023","author":"Njagi","year":"2023","journal-title":"Hum Reprod Open"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1472416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:12:08Z","timestamp":1733893928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1472416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":27,"alternative-id":["10.3389\/fonc.2024.1472416"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1472416","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"article-number":"1472416"}}